Selective serotonin reuptake inhibitors are associated with an increased risk of bleeding, most commonly intracranial and gastric bleeding, especially in conjunction with anticoagulant use. Although uncommon, escitalopram is associated with epistaxis in a dose-dependent manner. Dosage reduction may be sufficient in management.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11231925 | PMC |
| http://dx.doi.org/10.1002/ccr3.9128 | DOI Listing |
Publication Analysis
Top Keywords
feeling blue
4
blue red
4
red case
4
case escitalopram-induced
4
escitalopram-induced epistaxis
4
epistaxis selective
4
selective serotonin
4
serotonin reuptake
4
reuptake inhibitors
4
inhibitors associated
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!